Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
No Result
View All Result
Home Finance

Kashiv BioSciences: Secures INR 648 Crore Financing

Team Estrade by Team Estrade
January 1, 2026
in Finance, Hot News
0
Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India
Share on FacebookShare on Twitter

Kashiv BioSciences Private Limited (“Kashiv”), a biopharmaceutical company, today announced that it has secured financing of INR 648 crore from the Union Bank of India. The proceeds will be used to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat.

The new single-use commercial manufacturing facility will be one of India’s largest, equipped with cutting-edge technologies to support the production of high-quality biologics and specialty pharmaceuticals. At full capacity, Kashiv expects the facility to manufacture up to 50,000L. This milestone represents a major step forward in Kashiv’s mission to expand its global footprint and strengthen its position in India as a leading center for advanced biopharmaceutical manufacturing.

Serving customers across the U.S., Canada, Europe, and other international markets, the facility will further reinforce India’s role as the “pharmacy of the world” by enhancing technical capabilities, improving global competitiveness, and creating long-term, high-value employment across scientific, technical, and operational disciplines.

“This funding marks a pivotal milestone in Kashiv’s journey to expand biomanufacturing capacity in India,” said Dr. Sandeep Athalye, Global CEO of Kashiv BioSciences . “The new facility in Pipan will not only accelerate innovation and access to high-quality biologics but also reinforce our commitment to building world-class infrastructure that supports global healthcare needs. This infrastructure is being financed with the support of the Union Bank of India and is in alignment with the Biotechnology Policy and schemes implemented by GSBTM (Gujarat State Biotechnology Mission), a body of the state government, which continues to catalyze investment in advanced biopharmaceutical manufacturing.”

Related Post

16 Alpha Appoints 22-Year-Old Priyanshu Priyank, Making Him India’s Youngest Fund Manager

16 Alpha: Appoints 22‑year‑old Priyanshu Priyank as India’s youngest fund manager

November 2, 2026
Panasonic and ANACITY signed a Memorandum of Understanding in Bengaluru to bring integrated smart-home solutions for residential communities in India

Panasonic Life Solutions India: Partners with ANACITY for Integrated Smart-Home Solutions

October 31, 2026

NPCI: Explores Who Pays for UPI and Future Plans

October 31, 2026

Manipal University Jaipur: Celebrates Day 1 of 13th Convocation with 4,100 Graduates

October 31, 2026

Shri Digvijaysinh D. Jadeja, IAS, Mission Director (MD) of the GSBTM said, “Kashiv’s expansion in Pipan exemplifies Gujarat’s commitment to fostering innovation-led growth in biotechnology. Through the Biotechnology Policy, we continue to support high-impact investments that elevate India’s scientific capabilities and create meaningful employment across the value chain.”

“Union Bank is proud to have partnered with Kashiv as the lender on this initiative. This will advance India’s manufacturing capabilities and create sustainable economic value for the region, supporting the nation in achieving its goal of ‘Viksit and Atmanirbhar Bharat’. We wish the Company great success in this endeavor,” said a senior representative from the Union Bank of India.

About Kashiv BioSciences:

Kashiv BioSciences Private Limited, a fully owned subsidiary of Kashiv BioSciences, LLC is a biopharmaceutical company with numerous commercial and advanced clinical-stage assets and is among the few companies to both manufacture and receive marketing authorization for multiple biosimilars. Kashiv BioSciences, LLC in the USA, and its subsidiaries in India (together “Kashiv BioSciences”) operate together with robust infrastructure and highly skilled teams that provide global R&D, clinical, manufacturing, regulatory, and IP capabilities. We believe our people, partners, and shared purpose fuel our work to advance patient care and access to important medicines.

For more information, please visit www.kashivbiosciences.com and follow us on LinkedIn .

Source: Business Wire India

Donation

Buy author a coffee

Donate
Tags: biologicsBiotechfinancingGujaratindiamanufacturingpharmaceuticals
Team Estrade

Team Estrade

Related Posts

16 Alpha Appoints 22-Year-Old Priyanshu Priyank, Making Him India’s Youngest Fund Manager
Finance

16 Alpha: Appoints 22‑year‑old Priyanshu Priyank as India’s youngest fund manager

by Team Estrade
November 2, 2026
Nikhil Kamath Sits Down With The People Behind Your Payments Network to Ask Who Really Pays for UPI, and What Comes Next
Finance

NPCI: Explores Who Pays for UPI and Future Plans

by Team Estrade
October 31, 2026
Panasonic and ANACITY signed a Memorandum of Understanding in Bengaluru to bring integrated smart-home solutions for residential communities in India
Hot News

Panasonic Life Solutions India: Partners with ANACITY for Integrated Smart-Home Solutions

by Team Estrade
October 31, 2026
Next Post
The Founding Team of Mikro Grafeio, with Expertise Across HR, Operations, Organisational Design, Technology, and Analytics

Mikro Grafeio: Leads Tier-2 City Enterprise Growth

Recommended

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award (PRNewsfoto/Innoviti Technologies Pvt. Ltd.)

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award

December 18, 2025

Ebix Inc.: Joins NeoProEd Insurance Conclave as Gold Partner in GIFT City

September 21, 2026
India's First Women's Pro Volleyball League Builds Squads with Rs 1.5 Crore Investment

Women’s Pro Volleyball League: Launches with Rs 1.5 Crore Player Investment

October 26, 2026
Noida Expressway Emerges As Ncr Apos S Fastest Growing Luxury Housing Corridor

ANAROCK: Noida Expressway Redefines Luxury Living

June 10, 2026
SPJIMR #2 in India and #15 globally in Financial Times

S.P. Jain Institute of Management & Research (SPJIMR): Ranks No. 42 in The Case Centre Impact Index 2026

November 2, 2026
CRIF Launches Ahmedabad Chapter of ‘Credit Goes to HER’ to Advance Women’s Financial Empowerment

CRIF: Launches Ahmedabad Chapter of Credit Goes to HER for Women’s Financial Empowerment

November 2, 2026
Deakin University and CHL partner with IIT Roorkee

IIT Roorkee and Deakin University: Launch Crisis Leadership Training

November 2, 2026
30 Sundays Releases Insights on How Bali Travel Has Changed for Indian Couples

30 Sundays: Indian Couples Shift to Split Stays and Island Overnights in Bali

November 2, 2026
Estrade

We are a business news focused digital platform. Our vision is to provide a stage to businesses and corporate houses who are on a growth trajectory.

Get in Touch : info@estrade.in

Stay ahead with Estrade Business Media

Get the latest in business!


    Categories

    • Education
    • Finance
    • Hot News
    • Lifestyle & Leisure
    • Real Estate
    • Spotlight
    • Technology

    © 2025 Estrade | Engineered by WEBINEERING.

    No Result
    View All Result
    • Finance
    • Real Estate
    • Tech
    • Education
    • Lifestyle & Leisure
    • Estrade Awards

    © 2025 Estrade | Engineered by WEBINEERING.